BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Apr 04, 2011
 |  BC Week In Review  |  Company News  |  Other News

Antisoma cancer news

Antisoma said it will seek partners for its development programs after concluding an offer period soliciting a sale of the biotech. Antisoma said it concluded the offer period to take a longer-term approach to explore strategic options for the company's assets. Antisoma also said it will not commit further investment to its development programs and will not consider any offers to issue share capital of the company.

In January, Antisoma announced plans to restructure after discontinuing development of amonafide (AS1413), which missed the primary endpoint in...

Read the full 411 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >